| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |